Preview: Bio Inc. Redemption

It’s egregious medical malpractice made fun!

Not everyone was born to be a doctor; some of us simply don’t have the capacity to comprehend all of the medical lingo and technicalities, or the desire to spend that damn long in school. More significantly, not everyone was born with the desire to flood a human being with as many diseases, disorders and illnesses as they possibly can with the sheer intent of torturing them before things become fatal… Quite honestly, I’d like to hope that no such person would actually exist. Garnering a taste for either lifestyle has apparently never been easier, and it’s all thanks to Bio Inc. Redemption.

DryGin Studios’ medical malpractice simulator stems from the roots of its mobile predecessor, Bio Inc, which has impressively achieved over 15 million downloads. Bio Inc. Redemption is currently available on Windows PC via Steam Early Access, giving fans, aspiring doctors and even secret psychopaths an opportunity to be as experimental as possible when either saving a life or taking one.

Even in its early developmental stages, Bio Inc. Redemption is impressively detailed, currently offering players 18 unique medical cases, divided evenly between the Life and Death campaigns. There’s also already a ton of replay value on hand, given that each unique medical case features four difficulty settings and an adaptive artificial intelligence that attempts to strategically counter your every move.

What’s equally remarkable is how the game manages to accurately describe over 600 real-life diagnostic tests, diseases, treatment processes, and other medical conditions. For instance, anyone looking for a fun way of learning about the difference between Type 1 and Type 2 Diabetes, how the pair can be treated, and how likely it is that each treatment method effectively cures each condition, can easily take to Bio Inc. Redemption as an effective starting point. The game also does a good job of pointing out the many different factors that can either enhance the damages caused by these diseases and medical conditions or neutralise them, such as heredity and environmental influences, or even an addiction to junk food!

Above all else, Bio Inc. Redemption is far more strategic than you’d expect. Infecting a patient with seemingly random diseases might be enough to successfully kill them on a lower difficulty setting, but evolving specific diseases and pairing them with others at certain times is crucial to overcoming a cunning A.I. opponent on a harder difficulty. The game also requires a great deal of your attention; evolving diseases or treating them requires the accumulation of Bio Points, which must be harvested from the patient throughout the playing experience.

The full version looks quite promising as well, particularly due to the announced inclusion of a multiplayer feature, where two players can work against one another to either save or kill a patient. There are also more diseases and challenging cases on the way, as well as a sandbox mode for anyone looking to get a little more “experimental”.

DryGin studios has not indicated when the game will emerge from Steam Early Access with more content as of this writing, but Bio Inc. Redemption should do more than satisfy players in its present form. It’s a genuinely rewarding experience that goes far deeper than one might expect it to; it’s exciting to imagine just how much better the full release is going to be!

Final thoughts:

DryGin studios certainly seems to be the kind of team that is listening to its fanbase and constantly working to improve upon an already-impressive product. Bio Inc. Redemption has thus far been constructed based on some clever concepts, and there’s certainly a lot to look forward to about it in the hopefully-near future.

We previewed Bio Inc. Redemption using a pre-release code supplied by the publisher.